An FDA application for TAR-200 to treat BCG-unresponsive high-risk non-muscle-invasive bladder cancer is under real-time ...
This lies against a backdrop of a nationwide shortage of BCG vaccines, as reports indicated that it has been out of stock for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback